PlainRecalls
FDA Drug Moderate Class II Terminated

Travoprost Ophthalmic Solution, USP, 0.004%, 2.5 mL bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC 0378-9651-32.

Reported: April 13, 2022 Initiated: April 1, 2022 #D-0748-2022

Product Description

Travoprost Ophthalmic Solution, USP, 0.004%, 2.5 mL bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC 0378-9651-32.

Reason for Recall

Subpotent Drug and Failed Impurities/Degradation Specifications: low out-of-specification results obtained for assay and high out-of-specification results for related substance impurities/degradation during routine stability testing.

Details

Recalling Firm
Mylan Pharmaceuticals Inc
Units Affected
20,112 bottles
Distribution
Nationwide in the USA and Puerto Rico
Location
Morgantown, WV

Frequently Asked Questions

What product was recalled?
Travoprost Ophthalmic Solution, USP, 0.004%, 2.5 mL bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC 0378-9651-32.. Recalled by Mylan Pharmaceuticals Inc. Units affected: 20,112 bottles.
Why was this product recalled?
Subpotent Drug and Failed Impurities/Degradation Specifications: low out-of-specification results obtained for assay and high out-of-specification results for related substance impurities/degradation during routine stability testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 13, 2022. Severity: Moderate. Recall number: D-0748-2022.